论文部分内容阅读
目的观察 VAD 方案在治疗多发性骨髓瘤(MM)中的疗效。方法确诊多发性骨髓瘤的患者行 VAD 方案(长春地辛1 mg/d,第1～4天静脉滴注,表阿霉素20 mg/d,第1～4天静脉滴注,地塞米松40 mg/d,第1～4天,9～12天,17～20天静脉滴注。所有病例均在血液科化疗病房中化疗,化疗前后均采用相应的对症支持治疗,如输红细胞、血小板、抗感染等。结果 40例 MM 患者治疗后,初治组18
Objective To observe the efficacy of VAD regimen in the treatment of multiple myeloma (MM). Methods Patients with multiple myeloma diagnosed underwent VAD regimen (vindesine 1 mg / d, intravenous drip on day 1 to 4 and epirubicin 20 mg / d on days 1 to 4, dexamethasone 40 mg / d, days 1 to 4, days 9 to 12 and days 17 to 20. All cases were treated with chemotherapy in hematology and chemotherapy wards, and the corresponding symptomatic and supportive treatments were used before and after chemotherapy, such as transfusion of red blood cells, platelets , Anti-infection, etc. Results 40 cases of MM patients after treatment, naive group 18